However, in spite of the fact that correction of metabolic acidosis with nutritional therapy and/or oral administration of sodium bicarbonate in CKD is widely used [8–10], it is unknown whether correction of metabolic acidosis reduces IR and/or improves insulin effects on target cells in diabetic subjects. This evidence concerns the gene INS and chronic kidney disease.